Calcitriol ointment: A review of a topical vitamin D analog for psoriasis

Journal of Dermatological Treatment

Volumn 20, Issue 4, 2009, Pages 208-212

  Sigmon, Justin R ^a   Yentzer, Brad A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Efficacy; Safety; Silkis; Tolerance; Vectical

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; PLACEBO; TACALCITOL; UNCLASSIFIED DRUG; VECTICAL; VITAMIN D DERIVATIVE;

CALCIUM HOMEOSTASIS; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; ERYTHEMA; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; LABORATORY TEST; MONOTHERAPY; OINTMENT; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; REVIEW; SIDE EFFECT; SKIN DISCOMFORT; TOXICITY; UNITED STATES;

ADMINISTRATION, CUTANEOUS; CALCITRIOL; HUMANS; OINTMENTS; PSORIASIS; VITAMIN D;

EID: 69049118609     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630902936810     Document Type: Review

References (25)

1. Rizova E, Corroller M. Topical calcitriol - Studies on local tolerance and systemic safety. Br J Dermatol. 2001;144: (suppl 58)3-10. (Pubitemid 32374822)
2. Barker JN, Berth-jones J, Groves R, Omerod AD, Rizova E, Griffiths CE Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis. J Dermatolog Treat. 2003;14:14-21. (Pubitemid 36417422)
3. Carboni I, de Felice C, Bergamin A, Chimenti S. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: Results from an open-label study. J Eur Acad Dermatol Venereol. 2005;19:(suppl 3)11-13. (Pubitemid 41726920)
4. Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, et al. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. J Eur Acad Dermatol Venereol. 2007;21:466-472 (Pubitemid 46454898)
5. Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, et al. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: Results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol. 2007;6:428-435
6. Ortonne JP, Humbert P, Nicolas JF, Tsankov N, Tonev SD, Janin A, et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol. 2003;148:326-333 (Pubitemid 36278976)
7. Van de Kerkhof PCM. Psoriasis. In: Bolognia J, Jorizzo J, Rapini R, editors. Dermatology. London, New York: Mosby; 2003:127-138.
8. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: A cell biological study. Br J Dermatol. 1993;128:666-673
9. Gorman S, Kuritzky LA, Judge MA, Dixon KM, Mcglade JP, Mason RS, et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol. 2007;179:6273-6283
10. Langner A, Ashton p, Van de Kerlhof PC, Verjans H. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol. 1996;135:385-389
11. Queille-roussel C, Duteil L, Parneix-spake A, Arsonnaud S, Rizova E. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. Eur J Dermatol. 2001;11:219-224 (Pubitemid 32472673)
12. Birlea SA, Costin GE, Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets. 2008;9:345-359
13. Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res. 2004;24:11-14 (Pubitemid 39535380)
14. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol. 2001;145:472-475 (Pubitemid 32953706)
15. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol. 2001;145:476-479 (Pubitemid 32953707)
16. Emtestam L, Weden U. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol. Br J Dermatol. 1996;135:644-646 (Pubitemid 26340285)
17. Rajpara SM, King CM. Hailey-Hailey disease responsive to topical calcitriol. Br J Dermatol. 2005;152:816-817 (Pubitemid 40571330)
18. Urbina F, Misad C, Gonzalez S Circumscribed palmar hypokeratosis: Clinical evolution and ultrastructural study after prolonged treatment with topical calcipotriol. J Eur Acad Dermatol Venereol. 2005;19:491-494 (Pubitemid 40946109)
19. Godic A, Dragos V. Successful treatment of Netherton's syndrome with topical calcipotriol. Eur J Dermatol. 2004;14:115-117 (Pubitemid 38510028)
20. Gupta S, Saraswat A, Kumar B. Treatment of genital lichen sclerosus with topical calcipotriol. Int J STD AIDS. 2005;16:772-774 (Pubitemid 41659546)
21. Imagawa I, Suzuki H. Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1 alpha, 25-dihydroxy-22- oxacalcitriol) in 17 patients. J Dermatol. 2007;34:264-266 (Pubitemid 46365250)
22. Mota AV, Correia TM, Lopes JM, Guimaraes JM. Successful treatment of Grover's disease with calcipotriol. Eur J Dermatol. 1998;8:33-35 (Pubitemid 28264147)
23. Tay YK Topical calcipotriol ointment in the treatment of morphea. J Dermatolog Treat. 2003;14:219-221 (Pubitemid 37474532)
24. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998;39:211-215 (Pubitemid 28367331)
25. Bayramgurler D, Apaydin R, Bilen N. Limited benefit of topical calcipotriol in lichen planus treatment: A preliminary study. J Dermatolog Treat. 2002;13:129-132